tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MDGL Stock Latest News

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesMadrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3d ago
MDGL
Madrigal: Rezdiffra available in the U.S. for noncirrhotic NASH
PremiumThe Fly
Madrigal: Rezdiffra available in the U.S. for noncirrhotic NASH
11d ago
MDGL
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16d ago
MDGL
Madrigal Pharmaceuticals price target raised to $405 from $325 at Evercore ISI
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $405 from $325 at Evercore ISI
1M ago
MDGL
Madrigal Pharmaceuticals 750K share Spot Secondary priced at $260.00
PremiumThe Fly
Madrigal Pharmaceuticals 750K share Spot Secondary priced at $260.00
1M ago
MDGL
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
PremiumPress ReleasesMadrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
1M ago
MDGL
Madrigal Pharmaceuticals Announces Proposed Public Offering
PremiumPress Releases
Madrigal Pharmaceuticals Announces Proposed Public Offering
1M ago
MDGL
Madrigal Pharmaceuticals announces $500M common stock offering
PremiumThe Fly
Madrigal Pharmaceuticals announces $500M common stock offering
1M ago
MDGL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AGE
AKBA
BofA says 89bio should trade with strength after ‘win for entire MASH space’
PremiumThe Fly
BofA says 89bio should trade with strength after ‘win for entire MASH space’
1M ago
ETNB
MDGL
Madrigal Stock Rises on FDA Approval
PremiumMarket News
Madrigal Stock Rises on FDA Approval
1M ago
MDGL
DoorDash upgraded, GM initiated: Wall Street’s top analyst calls
PremiumThe Fly
DoorDash upgraded, GM initiated: Wall Street’s top analyst calls
1M ago
GM
DFS
Unusually active option classes on open March 15th
PremiumThe FlyUnusually active option classes on open March 15th
1M ago
CVX
LQD
Madrigal Pharmaceuticals price target raised to $410 from $337 at UBS
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $410 from $337 at UBS
1M ago
MDGL
Madrigal Pharmaceuticals price target raised to $375 from $320 at Oppenheimer
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $375 from $320 at Oppenheimer
1M ago
MDGL
Madrigal Pharmaceuticals price target raised to $390 from $349 at TD Cowen
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $390 from $349 at TD Cowen
1M ago
MDGL
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
PremiumThe Fly
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
1M ago
MDGL
VKTX
Madrigal Pharmaceuticals price target raised to $377 from $338 at Canaccord
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $377 from $338 at Canaccord
1M ago
MDGL
Viking Therapeutics price target raised to $100 from $86 at BTIG
PremiumThe Fly
Viking Therapeutics price target raised to $100 from $86 at BTIG
1M ago
MDGL
VKTX
Madrigal Pharmaceuticals price target raised to $389 from $382 at Citi
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $389 from $382 at Citi
1M ago
MDGL
Madrigal Pharmaceuticals’ Rezdiffra™ Wins Accelerated FDA Approval
PremiumCompany Announcements
Madrigal Pharmaceuticals’ Rezdiffra™ Wins Accelerated FDA Approval
1M ago
8K
MDGL
Madrigal price target raised to $425 from $405 at H.C. Wainwright
PremiumThe Fly
Madrigal price target raised to $425 from $405 at H.C. Wainwright
1M ago
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >